Skip to content

Author

Ben Youngblood

We have 1 of 15 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Epigenetic reprogramming of terminal T cell differentiation via DNMT1 inhibition reverses terminal DNA methylation and enhances multipotency 2259880

An epigenetic approach is described that facilitates the reversal of repressive DNA methylation and is used to alter the fate of T cell subsets for immunotherapy and is now used to alter the fate of T cell subsets for immunotherapy.

A. Norman, Ben Youngblood, Caitlin C. Zebley · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.